dr. agarwal on potential agents for metastatic hormone-sensitive prostate cancer
Published 7 years ago • 68 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:37
dr. agarwal on drug development in metastatic castration-sensitive prostate cancer
-
1:44
dr. agarwal on the stampede and latitude trials for prostate cancer
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
3:27
treating hormone sensitive metastatic prostate cancer
-
1:32
dr. agarwal on treatment for newly diagnosed prostate cancer
-
1:50
dr. agarwal on pfs2 data from the titan trial in mcspc
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:02
dr. agarwal on the safety profile of enzalutamide/talazoparib in mcrpc
-
2:05
dr. kohli on sequencing concerns in metastatic hormone-sensitive prostate cancer
-
1:05
dr. agarwal on androgen receptor inhibitors for prostate cancer
-
0:57
dr. agarwal on the tolerability of apalutamide in mcspc
-
1:05
dr. agarwal on candidates for docetaxel versus abiraterone and prednisone
-
1:37
dr. agarwal on the talapro-2 trial in mcrpc
-
5:20
hormone-sensitive prostate cancer
-
2:13
dr. agarwal on the cosmic-021 trial design in castration-resistant prostate cancer
-
7:00
hormone-sensitive prostate cancer: nuances in therapy
-
1:00
dr. aggarwal on androgen deprivation therapy for prostate cancer
-
9:23
hormone-sensitive metastatic prostate cancer
-
1:24
dr. higano on docetaxel for hormone-sensitive prostate cancer